BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 18691650)

  • 1. Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100.
    Goddeeris C; Willems T; Houthoofd K; Martens JA; Van den Mooter G
    Eur J Pharm Biopharm; 2008 Nov; 70(3):861-8. PubMed ID: 18691650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Matrix Tablets Based on Eudragit®E100/Carbopol®971P Combinations for Controlled Release and Improved Compaction Properties of Water Soluble Model Drug Paracetamol.
    Obeidat WM; Nokhodchi A; Alkhatib H
    AAPS PharmSciTech; 2015 Oct; 16(5):1169-79. PubMed ID: 25724162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indinavir-loaded pH-sensitive microparticles for taste masking: toward extemporaneous pediatric anti-HIV/AIDS liquid formulations with improved patient compliance.
    Chiappetta DA; Carcaboso AM; Bregni C; Rubio M; Bramuglia G; Sosnik A
    AAPS PharmSciTech; 2009; 10(1):1-6. PubMed ID: 19127436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering pH-sensitive dissolution of lipid-polymer nanoparticles by Eudragit integration impacts plasmid DNA (pDNA) transfection.
    Santhanes D; Zhang H; Wilkins A; John Aitken R; Gannon AL; Liang M
    Eur J Pharm Biopharm; 2024 Jun; 199():114299. PubMed ID: 38643953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid dispersion systems for enhanced dissolution of poorly water-soluble candesartan cilexetil: In vitro evaluation and simulated pharmacokinetics studies.
    Ali ISM; Sajad UA; Abdul Rasool BK
    PLoS One; 2024; 19(6):e0303900. PubMed ID: 38843120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Nok": a phytosterol-based amphiphile enabling transition-metal-catalyzed couplings in water at room temperature.
    Klumphu P; Lipshutz BH
    J Org Chem; 2014 Feb; 79(3):888-900. PubMed ID: 24447127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TPGS-750-M: a second-generation amphiphile for metal-catalyzed cross-couplings in water at room temperature.
    Lipshutz BH; Ghorai S; Abela AR; Moser R; Nishikata T; Duplais C; Krasovskiy A; Gaston RD; Gadwood RC
    J Org Chem; 2011 Jun; 76(11):4379-91. PubMed ID: 21548658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of talc and vitamin E TPGS on manufacturability, stability and release properties of trilaurin-based formulations for hot-melt coating.
    Huynh VT; de Paiva Lacerda S; Espitalier F; Beyssac E; Ré MI
    Int J Pharm; 2024 Mar; 653():123866. PubMed ID: 38286194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Polymers as Crystal Inhibitors to Prevent the Crystallization of the Rotigotine Patch.
    Liu Q; Li X; Liu B; Kong J; Wang Q; Gao Z
    Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Molecular Structure and Physicochemical Properties of Immunosuppressive Drugs on Micelle Formulation Characteristics and Cutaneous Delivery.
    Quartier J; Lapteva M; Boulaguiem Y; Guerrier S; Kalia YN
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing Cellular Uptake and Permeation of Curcumin Using a Novel Polymer-Surfactant Formulation.
    Liu Z; Lansley AB; Duong TN; Smart JD; Pannala AS
    Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug crystal growth in ternary amorphous solid dispersions: Effect of surfactants and polymeric matrix-carriers.
    Kapourani A; Tzakri T; Valkanioti V; Kontogiannopoulos KN; Barmpalexis P
    Int J Pharm X; 2021 Dec; 3():100086. PubMed ID: 34151251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Apremilast Solid Dispersion Using TPGS and PVPVA with Enhanced Solubility and Bioavailability.
    Yang L; Wu P; Xu J; Xie D; Wang Z; Wang Q; Chen Y; Li CH; Zhang J; Chen H; Quan G
    AAPS PharmSciTech; 2021 Apr; 22(4):142. PubMed ID: 33893566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unravelling the Miscibility of Poly(2-oxazoline)s: A Novel Polymer Class for the Formulation of Amorphous Solid Dispersions.
    Everaerts M; Tigrine A; de la Rosa VR; Hoogenboom R; Adriaensens P; Clasen C; Van den Mooter G
    Molecules; 2020 Aug; 25(16):. PubMed ID: 32781768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spray-Dried Amorphous Solid Dispersions of Griseofulvin in HPC/Soluplus/SDS: Elucidating the Multifaceted Impact of SDS as a Minor Component.
    Rahman M; Ahmad S; Tarabokija J; Parker N; Bilgili E
    Pharmaceutics; 2020 Feb; 12(3):. PubMed ID: 32106495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Perspectives for Fixed Dose Combinations of Poorly Water-Soluble Compounds: a Case Study with Ezetimibe and Lovastatin.
    Riekes MK; Engelen A; Appeltans B; Rombaut P; Stulzer HK; Van den Mooter G
    Pharm Res; 2016 May; 33(5):1259-75. PubMed ID: 26857899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing Mixing Quality of a Copovidone-TPGS Hot Melt Extrusion Process with Atomic Force Microscopy and Differential Scanning Calorimetry.
    Lamm MS; DiNunzio J; Khawaja NN; Crocker LS; Pecora A
    AAPS PharmSciTech; 2016 Feb; 17(1):89-98. PubMed ID: 26283196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and Pharmacokinetic Evaluation of Polymeric Dispersions Containing Valsartan.
    Chella N; Daravath B; Kumar D; Tadikonda RR
    Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):517-26. PubMed ID: 26156887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of solid dispersion for dissolution improvement of furosemide by cogrinding method.
    Siahi-Shadbad MR; Ghanbarzadeh S; Barzegar-Jalali M; Valizadeh H; Taherpoor A; Mohammadi G; Barzegar-Jalali A; Adibkia K
    Adv Pharm Bull; 2014 Dec; 4(4):391-9. PubMed ID: 25436197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission.
    Zhang T; Sturgis TF; Youan BB
    Eur J Pharm Biopharm; 2011 Nov; 79(3):526-36. PubMed ID: 21736940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.